Utility of Donor-Derived Cell Free DNA in Association With Gene Expression Profiling

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

December 31, 2019

Study Completion Date

February 29, 2020

Conditions
Cardiac Transplant FailureCardiac Transplant RejectionHeart Diseases
Trial Locations (28)

10029

Mount Sinai Hospital, New York

10032

Columbia University Medical Center, New York

15212

Allegheny General Hospital, Pittsburgh

15219

University of Pittsburgh Medical Center, Pittsburgh

19102

Drexel University, Philadelphia

23298

Virginia Commonwealth University, Richmond

30322

Emory University, Atlanta

33021

Memorial Regional Hospital, Hollywood

33606

Tampa General Hospital, Tampa

40536

University of Kentucky, Lexington

43210

Ohio State University, Columbus

44195

Cleveland Clinic Foundation, Cleveland

46260

St. Vincent Medical Group, Indianapolis

48109

University of Michigan, Ann Arbor

53215

Aurora St. Luke's Medical Center, Milwaukee

55455

University of Minnesota, Minneapolis

60637

University of Chicago, Chicago

63110

Washington University, St Louis

64111

Mid America Heart Institute - St. Luke's Hospital, Kansas City

70121

Ochsner Clinic Foundation, New Orleans

73112

Integris Baptist Medical Center, Oklahoma City

75246

Baylor Research Institute, Dallas

75390

UT Southwestern Medical Center, Dallas

77030

Baylor St. Lukes, Houston

84107

Intermountain Heart Institute, Murray

90095

University of California, Los Angeles, Los Angeles

90211

Cedars-Sinai Medical Center, Beverly Hills

94305

Stanford University, Stanford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

CareDx

INDUSTRY

NCT02178943 - Utility of Donor-Derived Cell Free DNA in Association With Gene Expression Profiling | Biotech Hunter | Biotech Hunter